DGLRX
Price
$21.80
Change
-$0.23 (-1.04%)
Updated
Nov 13 closing price
Net Assets
750.23M
FNPFX
Price
$74.25
Change
-$1.24 (-1.64%)
Updated
Nov 13 closing price
Net Assets
165.22B
Interact to see
Advertisement

DGLRX vs FNPFX

Header iconDGLRX vs FNPFX Comparison
Open Charts DGLRX vs FNPFXBanner chart's image
BNY Mellon Global Stock - I
Price$21.80
Change-$0.23 (-1.04%)
VolumeN/A
Net Assets750.23M
American Funds New Perspective F3
Price$74.25
Change-$1.24 (-1.64%)
VolumeN/A
Net Assets165.22B
DGLRX vs FNPFX Comparison Chart in %
View a ticker or compare two or three
VS
DGLRX vs. FNPFX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGLRX is a Buy and FNPFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FNPFX has more cash in the bank: 165B vs. DGLRX (750M). FNPFX pays higher dividends than DGLRX: FNPFX (0.73) vs DGLRX (0.41). DGLRX was incepted earlier than FNPFX: DGLRX (19 years) vs FNPFX (9 years). DGLRX (0.91) is less costly to investors than FNPFX (0.41). FNPFX is a more actively managed with annual turnover of: 24.00 vs. DGLRX (10.58). DGLRX has a lower initial minimum investment than FNPFX: DGLRX (1000) vs FNPFX (1000000). FNPFX annual gain was more profitable for investors over the last year : 15.05 vs. DGLRX (-6.11). FNPFX return over 5 years is better than : 35.52 vs. DGLRX (-14.02).
DGLRXFNPFXDGLRX / FNPFX
Total Expense Ratio0.910.41222%
Annual Report Gross Expense Ratio0.910.41222%
Fund Existence19 years9 years-
Gain YTD6.16921.56229%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets750M165B0%
Annual Yield % from dividends0.410.7356%
Returns for 1 year-6.1115.05-41%
Returns for 3 years-2.2951.95-4%
Returns for 5 years-14.0235.52-39%
Returns for 10 years20.82N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GALT5.830.33
+6.00%
Galectin Therapeutics
TPG58.611.62
+2.84%
TPG
CMRE14.460.28
+1.97%
Costamare
RFAIU10.85N/A
N/A
RF Acquisition Corp II
YSXT2.56-0.01
-0.39%
YSX Tech Co Ltd